Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Odivir 300 mg/250 mg/600 mg Kit
Manufacturer/Marketed By : Cipla Ltd
$1.21 $0.94
The Odivir Kit, available in strengths of 300 mg, 250 mg, and 600 mg, is a carefully formulated combination of antiretroviral agents, specifically Lamivudine, Didanosine, and Efavirenz, designed to effectively...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Lamivudine 300 mg + Didanosine 250 mg + Efavirenz 600 mg
Active Pharmaceutical Ingredient
Odivir 300 mg/250 mg/600 mg Kit
$1.21
$0.94
The Odivir Kit, available in strengths of 300 mg, 250 mg, and 600 mg, is a carefully formulated combination of antiretroviral agents, specifically Lamivudine, Didanosine, and Efavirenz, designed to effectively manage Human Immunodeficiency Virus (HIV) infections. Suitable for both adults and children over 35 kg, this innovative treatment option not only helps in controlling the viral load but also plays a crucial role in preventing the progression to acquired immunodeficiency syndrome (AIDS). By inhibiting the replication of the virus within the body, Odivir contributes to improved immune function and overall health. It is important for patients to adhere to the prescribed regimen to maximize efficacy and minimize the risk of resistance. Those considering this treatment should consult their healthcare provider to discuss any potential side effects and drug interactions. The Odivir Kit stands as a vital component in the comprehensive care of individuals living with HIV, promoting a better quality of life. Always remember to follow medical guidance for optimal results and safety.
Active Pharmaceutical Ingredient
Uses
• Odivir 300 mg 250 mg 600 mg kit is primarily used for the management of human immunodeficiency virus (HIV) infection. This condition significantly compromises the immune system, making individuals vulnerable to opportunistic infections. By employing this medication, patients can help control the viral load in their bodies. This contributes to improved health outcomes and enhances quality of life.
• The Odivir 300 mg 250 mg 600 mg kit serves as a critical component in antiretroviral therapy for individuals diagnosed with HIV. It aids in reducing the transmission risk of the virus to others. This is particularly important for maintaining sexual health and protecting partners. Regular use of this kit can also help prevent the progression to AIDS.
• Patients using the Odivir 300 mg 250 mg 600 mg kit can experience better immune function over time. By adhering to the treatment regimen, individuals often report fewer HIV-related complications. This allows them to lead more active and fulfilling lives. Additionally, it supports the long-term health of those living with HIV.
• The Odivir 300 mg 250 mg 600 mg kit is often prescribed in combination with other antiretroviral medications. This multi-drug approach enhances treatment efficacy and helps combat potential drug resistance. By utilizing this kit as part of a comprehensive treatment plan, healthcare providers can optimize patient outcomes. This strategy is essential for effective management of HIV infection.
Benefits
Treatment of HIV infection: Odivir 300 mg/250 mg/600 mg Kit works by inhibiting the multiplication of HIV in the body and improving the immune system's ability to fight the infection. Odivir Antiretroviral Kit can help manage the infection, reduce the risk of complications such as new infections, and improve the quality of life. It is important to note that this tablet is not a cure for HIV or AIDS, and should not be used for post-exposure prophylaxis. Following the doctor's prescribed dosage schedule is crucial to maximising the effectiveness of the medication and minimising the risk of drug-resistant HIV strains. It's important to understand that this medicine doesn't prevent the transmission of HIV to other people.
Side Effects
Odivir 300 mg/250 mg/600 mg Kit may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Headache
• Diarrhoea
• Tiredness
• Dizziness
• Skin Rashes
• Flatulence
Common Side Effects
• Tingling Sensation in hands and feet
• Insomnia
• Depression
• Low Count of Red Blood Cells
• Muscle Damage
• High Fever
• Mouth Dryness
How To Use
Odivir Kit for HIV triple therapy can be taken with or without food. It is best to take it at the regular time or exactly as prescribed by your doctor. Do not take more or less of the medication than directed. If you miss a dose of this tablet, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose. Do not crush, chew, or break the tablet.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Odivir 300 mg/250 mg/600 mg Kit. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Odivir 300 mg/250 mg/600 mg Kit should be used with caution in patients with kidney disease. Reduction of the dosage of Odivir 300 mg/250 mg/600 mg Kit is recommended for patients with impaired kidney function. Patients with creatinine clearance of less than 50 mL per min or patients on hemodialysis should not receive Odivir HIV Treatment Kit.
• Breastfeeding: HIV-positive women must not breastfeed, because HIV infection can be passed on to the baby in breast milk. A small amount of Odivir Antiretroviral Kit can also pass with breast milk.
• Liver: Odivir 300 mg/250 mg/600 mg Kit should be used with caution in patients with mild to moderate liver diseases. The reduction in the daily dose of Odivir 300 mg/250 mg/600 mg Kit may be necessary for patients with mild to moderate impaired liver disease or liver cirrhosis. Odivir 300 mg/250 mg/600 mg Kit is not recommended for patients with impaired hepatic function because it is a fixed-dose combination that cannot be adjusted.
• Pregnancy: Use of Odivir 300 mg/250 mg/600 mg Kit may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Odivir 300 mg/250 mg/600 mg Kit during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Odivir 300 mg/250 mg/600 mg Kit may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Odivir Kit for HIV triple therapy.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.